Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Helsingborg – page 33

1 322 clinical trials in Helsingborg, Sweden. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Helsingborg at a glance
1 322
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 322 trials in Helsingborg

Open in trial search

Neoplasm

Recruiting

Study of Zenocutuzumab for Patients with Solid Tumors with NRG1 Fusion

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Zenocutuzumab
  • Sponsor:Partner Therapeutics Inc.

Study on Cabozantinib and Drug Combination for Untreated Metastatic Renal Cell Carcinoma in Intermediate and Poor Risk Patients

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Axitinib
  • Sponsor:Institut Gustave Roussy

Study on the Safety and Tolerability of STK-002 for Patients with Autosomal Dominant Optic Atrophy

InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:STK-002
  • Sponsor:Stoke Therapeutics Inc.

Glioblastoma

Recruiting

Study on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Temozolomide
  • Sponsor:Region Oestergoetland

Study on the Safety and Effectiveness of Baricitinib for Children Aged 1 to 17 with Juvenile Idiopathic Arthritis

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:0–17 years
  • Substances:Baricitinib
  • Sponsor:Eli Lilly & Co.

Study on Long-Term Safety of Enzalutamide, Abiraterone, and Prednisolone for Patients with Prostate Cancer from Previous Enzalutamide Trials

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Astellas Pharma Global Development Inc.

Study on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Cyclophosphamide
  • Sponsor:Universitaetsklinikum Muenster AöR

Prostate cancer

Recruiting

Study on the Safety and Effectiveness of 64Cu-DOTA-AE105 PET Imaging for Patients with Localized, Untreated Prostate Cancer

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:64CU-dota-AE105
  • Sponsor:Curasight A/S

Sepsis+1

Recruiting

Study Comparing Meropenem and Piperacillin/Tazobactam for Adults with Sepsis

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Linezolid
  • Sponsor:Region Hovedstaden

Study Comparing Chemotherapy with Irinotecan, Folinic Acid, and Oxaliplatin for Patients with Locally Recurrent Rectal Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Catharina Ziekenhuis Stichting

Study of Metolazone and Acetazolamide Combination for Patients with Acute Heart Failure and Volume Overload

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acetazolamide
  • Sponsor:Region Hovedstaden

Study on the Safety and Effectiveness of TransCon CNP for Infants with Achondroplasia

Investigational
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Navepegritide
  • Sponsor:Ascendis Pharma Growth Disorders A/S

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Helsingborg

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies exploring treatments for heart failure and cardiovascular conditions, including research on combination therapies to reduce cardiovascular mortality.

  • Heart Failure Prevention
  • Atrial Fibrillation
  • Takotsubo Syndrome

Groundbreaking trials evaluating novel drug combinations and therapeutic approaches for cardiac conditions.

02 Oncology Studies

Advanced research focusing on multiple myeloma treatment, particularly for patients with relapsed or refractory conditions.

  • Blood Cancer Therapies
  • Combination Treatment Approaches
  • Bladder Cancer Management

Evaluating innovative therapeutic combinations and comparing effectiveness of different treatment regimens.

03 Infectious Diseases

Clinical investigations into treatments for various infections, including bacterial infections and antibiotic resistance.

  • Staphylococcus Aureus Treatment
  • Urinary Tract Infections
  • Viral Lung Infections

Studies focusing on alternative antibiotics and novel approaches to combat resistant infections.

04 Mental Health Research

Studies examining innovative treatments for psychiatric disorders, including treatment-resistant conditions.

  • Schizophrenia Spectrum Disorders
  • Treatment-Resistant Depression
  • Novel Therapeutic Approaches

Investigating immunomodulatory treatments and new compounds for mental health conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.